Skip to main content
SpringerLink
Log in

Treatment of myeloproliferative syndrome with hydroxyurea

  • LETTER TO THE EDITOR
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Ospedale Maggiore di Milano, Institute of Medical Science of the University, Via F. Sforza, 35, I-20122 Milan, Italy, , , , , , IT

    F. Radaelli, R. Calori, C. Ripamonti & P. Faccini

Authors
  1. F. Radaelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Calori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Ripamonti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Faccini
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 30 July 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radaelli, F., Calori, R., Ripamonti, C. et al. Treatment of myeloproliferative syndrome with hydroxyurea. Ann Hematol 73, 205 (1996). https://doi.org/10.1007/s002770050230

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050230

Search

Navigation